2-aminobicyclo(2,2,1)heptane-2-carboxylic acid has been researched along with Neoplasm Metastasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, Y; Fu, DR; Fukumoto, S; Hanazono, K; Iwano, H; Kadosawa, T; Uchide, T | 1 |
1 other study(ies) available for 2-aminobicyclo(2,2,1)heptane-2-carboxylic acid and Neoplasm Metastasis
Article | Year |
---|---|
A new treatment for human malignant melanoma targeting L-type amino acid transporter 1 (LAT1): a pilot study in a canine model.
Topics: Amino Acids, Cyclic; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dogs; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Large Neutral Amino Acid-Transporter 1; Melanoma; Melphalan; Neoplasm Metastasis; Pilot Projects | 2013 |